Goldman Sachs resumes coverage on Allscripts (NASDAQ: MDRX) with a Neutral. PT $15.00.

The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE